Follow
Huiquan Wu
Title
Cited by
Cited by
Year
Assessment of recent process analytical technology (PAT) trends: a multiauthor review
LL Simon, H Pataki, G Marosi, F Meemken, K Hungerbühler, A Baiker, ...
Organic Process Research & Development 19 (1), 3-62, 2015
4202015
Applications of process analytical technology to crystallization processes
XY Lawrence, RA Lionberger, AS Raw, R D'Costa, H Wu, AS Hussain
Advanced drug delivery reviews 56 (3), 349-369, 2004
4102004
Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design …
H Wu, M White, MA Khan
International journal of pharmaceutics 405 (1-2), 63-78, 2011
1432011
Quality-by-Design (QbD): An integrated multivariate approach for the component quantification in powder blends
H Wu, M Tawakkul, M White, MA Khan
International Journal of Pharmaceutics 372 (1-2), 39-48, 2009
1132009
Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: a noninvasive off-line calibration approach
Y Sulub, B Wabuyele, P Gargiulo, J Pazdan, J Cheney, J Berry, A Gupta, ...
Journal of pharmaceutical and biomedical analysis 49 (1), 48-54, 2009
932009
Process analytical technology (PAT): Quantification approaches in terahertz spectroscopy for pharmaceutical application
H Wu, EJ Heilweil, AS Hussain, MA Khan
Journal of pharmaceutical sciences 97 (2), 970-984, 2008
812008
Quality-by-design (QbD): an integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point
H Wu, MA Khan
Journal of pharmaceutical sciences 98 (8), 2784-2798, 2009
782009
Positron annihilation spectroscopy study of interfacial defects formed by dissolution of aluminum in aqueous sodium hydroxide
KR Hebert, H Wu, T Gessmann, K Lynn
Journal of the Electrochemical Society 148 (2), B92, 2001
692001
Process analytical technology (PAT): Effects of instrumental and compositional variables on terahertz spectral data quality to characterize pharmaceutical materials and tablets
H Wu, EJ Heilweil, AS Hussain, MA Khan
International Journal of Pharmaceutics 343 (1-2), 148-158, 2007
672007
A quantitative study of the effect of process parameters on key granule characteristics in a high shear wet granulation process involving a two component pharmaceutical blend
S Oka, O Kašpar, V Tokárová, K Sowrirajan, H Wu, M Khan, F Muzzio, ...
Advanced Powder Technology 26 (1), 315-322, 2015
652015
Process control perspective for process analytical technology: Integration of chemical engineering practice into semiconductor and pharmaceutical industries
H Wu, MA Khan, AS Hussain
Chemical Engineering Communications 194 (6), 760-779, 2007
622007
Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation …
LIN Xie, H Wu, M Shen, LL Augsburger, RC Lyon, MA Khan, AS Hussain, ...
Journal of pharmaceutical sciences 97 (10), 4485-4497, 2008
592008
Robust calibration design in the pharmaceutical quantitative measurements with near‐infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls
D Xiang, J Berry, S Buntz, P Gargiulo, J Cheney, Y Joshi, B Wabuyele, ...
Journal of pharmaceutical sciences 98 (3), 1155-1166, 2009
582009
Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms
AS Tatavarti, R Fahmy, H Wu, AS Hussain, W Marnane, D Bensley, ...
aaps Pharmscitech 6, E91-E99, 2005
552005
A mechanistic population balance model for granulation processes: effect of process and formulation parameters
A Chaudhury, H Wu, M Khan, R Ramachandran
Chemical Engineering Science 107, 76-92, 2014
532014
Quality‐by‐Design (QbD): An integrated process analytical technology (PAT) approach for real‐time monitoring and mapping the state of a pharmaceutical coprecipitation process
H Wu, MA Khan
Journal of pharmaceutical sciences 99 (3), 1516-1534, 2010
532010
Risk considerations on developing a continuous crystallization system for carbamazepine
X Yang, D Acevedo, A Mohammad, N Pavurala, H Wu, AL Brayton, ...
Organic Process Research & Development 21 (7), 1021-1033, 2017
522017
An integrated process analytical technology (PAT) approach for pharmaceutical crystallization process understanding to ensure product quality and safety: FDA scientist’s …
H Wu, Z Dong, H Li, M Khan
Organic Process Research & Development 19 (1), 89-101, 2015
482015
Population balance model development, validation, and prediction of CQAs of a high-shear wet granulation process: towards QbD in drug product pharmaceutical manufacturing
A Chaudhury, D Barrasso, P Pandey, H Wu, R Ramachandran
Journal of Pharmaceutical Innovation 9, 53-64, 2014
462014
THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical Process Analytical Technology (PAT) applications
H Wu, M Khan
Journal of Molecular Structure 1020, 112-120, 2012
432012
The system can't perform the operation now. Try again later.
Articles 1–20